Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute systemic knockdown of Atg7 is lethal and causes pancreatic destruction in shRNA transgenic mice.
Mainz L, Sarhan MAFE, Roth S, Sauer U, Kalogirou C, Eckstein M, Gerhard-Hartmann E, Seibert HD, Voelker HU, Geppert C, Rosenwald A, Eilers M, Schulze A, Diefenbacher M, Rosenfeldt MT. Mainz L, et al. Among authors: eckstein m. Autophagy. 2022 Dec;18(12):2880-2893. doi: 10.1080/15548627.2022.2052588. Epub 2022 Mar 28. Autophagy. 2022. PMID: 35343375 Free PMC article.
DAPK1 loss triggers tumor invasion in colorectal tumor cells.
Steinmann S, Kunze P, Hampel C, Eckstein M, Bertram Bramsen J, Muenzner JK, Carlé B, Ndreshkjana B, Kemenes S, Gasparini P, Friedrich O, Andersen C, Geppert C, Wang S, Eyupoglu I, Bäuerle T, Hartmann A, Schneider-Stock R. Steinmann S, et al. Among authors: eckstein m. Cell Death Dis. 2019 Nov 26;10(12):895. doi: 10.1038/s41419-019-2122-z. Cell Death Dis. 2019. PMID: 31772156 Free PMC article.
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients.
König P, Eckstein M, Jung R, Abdulrahman A, Guzman J, Weigelt K, Serrero G, Hayashi J, Geppert C, Stöhr R, Hartmann A, Wullich B, Wach S, Taubert H, Lieb V. König P, et al. Among authors: eckstein m. Cancers (Basel). 2020 Sep 16;12(9):2639. doi: 10.3390/cancers12092639. Cancers (Basel). 2020. PMID: 32947898 Free PMC article.
TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers.
Weyerer V, Eckstein M, Strissel PL, Wullweber A, Lange F, Tögel L, Geppert CI, Sikic D, Taubert H, Wach S, Wullich B, Hartmann A, Stoehr R, Giedl J. Weyerer V, et al. Among authors: eckstein m. Genes (Basel). 2021 Feb 5;12(2):230. doi: 10.3390/genes12020230. Genes (Basel). 2021. PMID: 33562516 Free PMC article.
Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort.
Weyerer V, Stoehr R, Bertz S, Lange F, Geppert CI, Wach S, Taubert H, Sikic D, Wullich B, Hartmann A, Eckstein M. Weyerer V, et al. Among authors: eckstein m. World J Urol. 2021 Nov;39(11):4011-4019. doi: 10.1007/s00345-021-03788-1. Epub 2021 Jul 14. World J Urol. 2021. PMID: 34259899 Free PMC article.
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer.
Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson MT, Schmitz W, Wach S, Krebs M, Hartmann E, Puhr M, Müller A, Spahn M, Seitz AK, Frank T, Marouf H, Büchel G, Eckstein M, Kübler H, Eilers M, Saar M, Junker K, Röhrig F, Kneitz B, Rosenfeldt MT, Schulze A. Kalogirou C, et al. Among authors: eckstein m. Nat Commun. 2021 Aug 20;12(1):5066. doi: 10.1038/s41467-021-25325-9. Nat Commun. 2021. PMID: 34417456 Free PMC article.
Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy.
Sikic D, Weyerer V, Geppert CI, Bertz S, Lange F, Taubert H, Wach S, Schmitz-Draeger BJ, Wullich B, Hartmann A, Eckstein M. Sikic D, et al. Among authors: eckstein m. Urol Oncol. 2022 Feb;40(2):63.e19-63.e26. doi: 10.1016/j.urolonc.2021.07.025. Epub 2021 Aug 20. Urol Oncol. 2022. PMID: 34420870
716 results